The importance of diabetes control
In the article*, “Better life and health when your diabetes is under control”, Professor Peter Rossing discusses the importance of diabetes control. Professor Rossing, who was a member of DUKADA’s Advisory Board, is Head of Clinical and Translational Research at Steno Diabetes Center Copenhagen.
Professor Rossing explains that many people living with diabetes need to monitor their blood glucose levels and take insulin regularly. Good diabetes control is essential for their daily health and quality of life, as well as for reducing the risk of long-term complications.
He also points out that disruptions to daily routines can make it easier to forget an insulin injection. Unusual situations may also make people feel less confident about injecting. However, he notes that “there are devices for insulin pens that support and remember the injection which you can use”.
These everyday challenges were among the reasons why DUKADA originally developed DUKADA Trio.
From DUKADA Trio to DUKADA Sense
DUKADA Trio was our first Smart Cap for insulin pens, originally developed for Novo Nordisk FlexPen and Sanofi SoloStar pens.
Its timer indicated the time since the last injection, while the Needle Light provided illumination in low-light conditions. The Flex Grip offered additional stability and control when handling the insulin pen, particularly for users with shaky hands or when injecting in less stable surroundings.
These features addressed practical needs identified in our earlier user surveys. Read more about the findings in our blog on the use of the insulin pen.
Although the original DUKADA Trio is no longer sold to individual consumers, its user-oriented approach remains central to our technology development.
Building on this experience, we have developed DUKADA Sense, a connected Smart Cap platform designed to automatically detect and record both the time and size of injection doses and wirelessly transfer the information to digital health applications.
DUKADA Sense – and DUKADA Trio – can be adapted to different injection pens and treatment areas. Today, DUKADA focuses on collaborating with pharmaceutical companies and injection pen manufacturers to develop Smart Cap solutions that combine ease of use with digital connectivity.
* The article was published on 29 December 2016 in a diabetes supplement to Danish newspapers Berlingske Tidende and BT. You can read the article “Together against diabetes” here (in Danish).